
Meridian Bioscience VIVO
Quarterly report 2023-Q1
added 05-16-2026
Meridian Bioscience Depreciation & Amortization 2011-2026 | VIVO
Annual Depreciation & Amortization Meridian Bioscience
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 16.5 M | 15.3 M | 13.6 M | 9.96 M | 8.69 M | 9.09 M | 7.72 M | 6.61 M | 7.26 M | 7.15 M | 6.6 M | 5.87 M | 4.68 M | 4.36 M | 2.86 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 16.5 M | 2.86 M | 8.41 M |
Quarterly Depreciation & Amortization Meridian Bioscience
| 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.64 M | 1.64 M | 5.01 M | 3.37 M | 1.7 M | 1.7 M | 4.73 M | 3.07 M | 1.51 M | 1.51 M | 3.76 M | 2.44 M | 1.22 M | 1.22 M | 3.98 M | 2.56 M | 1.25 M | 1.25 M | 3.32 M | 2.24 M | 1.15 M | 1.15 M | 3.26 M | 2.15 M | 1.08 M | 1.08 M | 2.87 M | 1.78 M | 896 K | 896 K | 2.58 M | 1.83 M | 927 K | 927 K | 2.63 M | 1.76 M | 888 K | 888 K | 2.52 M | 1.67 M | 815 K | 815 K | 2.66 M | 1.76 M | 903 K | 903 K | 2.52 M | 1.71 M | 845 K | 2.31 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 5.01 M | 815 K | 1.95 M |
Depreciation & Amortization of other stocks in the Diagnostics research industry
| Issuer | Depreciation & Amortization | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
1.27 M | - | -8.98 % | $ 14.8 K | ||
|
Heska Corporation
HSKA
|
14 M | - | - | $ 1.31 B | ||
|
Quest Diagnostics Incorporated
DGX
|
570 M | $ 206.18 | 0.82 % | $ 22.9 B | ||
|
Celcuity
CELC
|
167 K | $ 89.53 | -3.31 % | $ 4.19 B | ||
|
Akumin
AKU
|
98.2 M | - | -17.87 % | $ 25.9 M | ||
|
Co-Diagnostics
CODX
|
1.11 M | $ 4.63 | 2.88 % | $ 6.16 M | ||
|
Castle Biosciences
CSTL
|
40.8 M | $ 21.44 | 1.68 % | $ 621 M | ||
|
Fulgent Genetics
FLGT
|
24.1 M | $ 19.12 | 3.35 % | $ 588 M | ||
|
Aspira Women's Health
AWH
|
112 K | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
1.4 M | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
1.66 M | - | -13.05 % | $ 7.29 M | ||
|
ICON Public Limited Company
ICLR
|
383 M | $ 152.76 | 0.62 % | $ 12 B | ||
|
Guardant Health
GH
|
39.7 M | $ 131.71 | 1.22 % | $ 16.5 B | ||
|
Illumina
ILMN
|
270 M | $ 165.78 | 3.59 % | $ 25.7 B | ||
|
CareDx, Inc
CDNA
|
15 M | $ 23.21 | 2.02 % | $ 1.24 B | ||
|
Chembio Diagnostics
CEMI
|
2.55 M | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
161 K | - | - | $ 9.42 M | ||
|
Interpace Biosciences
IDXG
|
425 K | $ 1.74 | 3.57 % | $ 7.7 M | ||
|
HTG Molecular Diagnostics
HTGM
|
587 K | - | -20.0 % | $ 1.06 M | ||
|
Global Cord Blood Corporation
CO
|
43.3 M | - | - | $ 399 M | ||
|
DermTech
DMTK
|
200 K | - | -11.32 % | $ 2.94 M | ||
|
Lantheus Holdings
LNTH
|
70.1 M | $ 102.44 | 2.46 % | $ 6.91 B | ||
|
Charles River Laboratories International
CRL
|
403 M | $ 193.18 | 1.68 % | $ 9.57 B | ||
|
Pacific Biosciences of California
PACB
|
13 M | $ 1.42 | 3.28 % | $ 426 M | ||
|
Medpace Holdings
MEDP
|
27.2 M | $ 475.39 | 1.84 % | $ 13.7 B | ||
|
Exact Sciences Corporation
EXAS
|
125 M | - | - | $ 19.8 B | ||
|
Mettler-Toledo International
MTD
|
51.1 M | $ 1 162.13 | -0.07 % | $ 24 B | ||
|
NeoGenomics
NEO
|
36.1 M | $ 11.74 | 2.62 % | $ 1.5 B | ||
|
Myriad Genetics
MYGN
|
53.7 M | $ 4.66 | 2.53 % | $ 432 M | ||
|
National Research Corporation
NRC
|
7.62 M | $ 20.98 | 6.23 % | $ 470 M | ||
|
Natera
NTRA
|
41.8 M | $ 222.41 | -0.19 % | $ 30.4 B | ||
|
Personalis
PSNL
|
10 M | $ 10.26 | 5.23 % | $ 916 M | ||
|
Koninklijke Philips N.V.
PHG
|
1.12 B | $ 25.84 | -2.49 % | $ 24.5 B | ||
|
Senseonics Holdings
SENS
|
1.51 M | $ 7.65 | 2.9 % | $ 319 M | ||
|
QIAGEN N.V.
QGEN
|
194 M | - | - | $ 10.6 B | ||
|
Soleno Therapeutics
SLNO
|
2.02 M | - | - | $ 2.69 B | ||
|
Biomerica
BMRA
|
87 K | $ 2.03 | -1.02 % | $ 4.66 M | ||
|
Laboratory Corporation of America Holdings
LH
|
681 M | $ 274.38 | 1.17 % | $ 22.8 B | ||
|
Thermo Fisher Scientific
TMO
|
1.05 B | $ 492.63 | -0.34 % | $ 186 B | ||
|
Motus GI Holdings
MOTS
|
451 K | - | -34.28 % | $ 263 K | ||
|
Twist Bioscience Corporation
TWST
|
24.9 M | $ 70.12 | 0.09 % | $ 4.19 B | ||
|
Neogen Corporation
NEOG
|
119 M | $ 9.32 | 0.38 % | $ 2.02 B | ||
|
Invitae Corporation
NVTA
|
142 M | - | - | $ 21.2 M |